IT201700060645A1 - Uso di xibornolo come agente attivo nel trattamento dell’acne volgare - Google Patents

Uso di xibornolo come agente attivo nel trattamento dell’acne volgare

Info

Publication number
IT201700060645A1
IT201700060645A1 IT102017000060645A IT201700060645A IT201700060645A1 IT 201700060645 A1 IT201700060645 A1 IT 201700060645A1 IT 102017000060645 A IT102017000060645 A IT 102017000060645A IT 201700060645 A IT201700060645 A IT 201700060645A IT 201700060645 A1 IT201700060645 A1 IT 201700060645A1
Authority
IT
Italy
Prior art keywords
volgare
xibornol
acne
treatment
active agent
Prior art date
Application number
IT102017000060645A
Other languages
English (en)
Inventor
Silvia Trasciatti
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Priority to IT102017000060645A priority Critical patent/IT201700060645A1/it
Priority to US16/616,570 priority patent/US20200155478A1/en
Priority to CN201880035203.0A priority patent/CN110691591A/zh
Priority to EP18734619.2A priority patent/EP3630081A1/en
Priority to JP2019564941A priority patent/JP2020521746A/ja
Priority to PCT/IB2018/053837 priority patent/WO2018220544A1/en
Publication of IT201700060645A1 publication Critical patent/IT201700060645A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT102017000060645A 2017-06-01 2017-06-01 Uso di xibornolo come agente attivo nel trattamento dell’acne volgare IT201700060645A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT102017000060645A IT201700060645A1 (it) 2017-06-01 2017-06-01 Uso di xibornolo come agente attivo nel trattamento dell’acne volgare
US16/616,570 US20200155478A1 (en) 2017-06-01 2018-05-30 Xibornol for use in the treatment of acne vulgaris
CN201880035203.0A CN110691591A (zh) 2017-06-01 2018-05-30 用于在治疗寻常痤疮中使用的希波酚
EP18734619.2A EP3630081A1 (en) 2017-06-01 2018-05-30 Xibornol for use in the treatment of acne vulgaris
JP2019564941A JP2020521746A (ja) 2017-06-01 2018-05-30 尋常性ざ瘡の治療における活性剤としてのキシボルノールの使用
PCT/IB2018/053837 WO2018220544A1 (en) 2017-06-01 2018-05-30 Xibornol for use in the treatment of acne vulgaris

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000060645A IT201700060645A1 (it) 2017-06-01 2017-06-01 Uso di xibornolo come agente attivo nel trattamento dell’acne volgare

Publications (1)

Publication Number Publication Date
IT201700060645A1 true IT201700060645A1 (it) 2018-12-01

Family

ID=60182900

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000060645A IT201700060645A1 (it) 2017-06-01 2017-06-01 Uso di xibornolo come agente attivo nel trattamento dell’acne volgare

Country Status (6)

Country Link
US (1) US20200155478A1 (it)
EP (1) EP3630081A1 (it)
JP (1) JP2020521746A (it)
CN (1) CN110691591A (it)
IT (1) IT201700060645A1 (it)
WO (1) WO2018220544A1 (it)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU694576B2 (en) * 1994-10-21 1998-07-23 Merck & Co., Inc. Combination method for acne treatment
WO2010148288A2 (en) * 2009-06-19 2010-12-23 Lyotropic Therapeutics, Inc. Pharmaceutical formulations with low aqueous levels of free unbound drug
JP2016507532A (ja) * 2013-02-08 2016-03-10 ルオダ ファーマ ピーティーワイ リミテッド 局所微生物感染を処置する方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CIRRI ET AL: "Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER, AMSTERDAM, NL, vol. 340, no. 1-2, 19 July 2007 (2007-07-19), pages 84 - 91, XP022152594, ISSN: 0378-5173, DOI: 10.1016/J.IJPHARM.2007.03.021 *
SANJAY K RATHI: "ACNE VULGARIS TREATMENT : THE CURRENT SCENARIO", 1 February 2011 (2011-02-01), XP055439041, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088940/?report=printable> [retrieved on 20180109] *

Also Published As

Publication number Publication date
EP3630081A1 (en) 2020-04-08
JP2020521746A (ja) 2020-07-27
US20200155478A1 (en) 2020-05-21
WO2018220544A1 (en) 2018-12-06
CN110691591A (zh) 2020-01-14

Similar Documents

Publication Publication Date Title
DK3706796T3 (da) Eksosomerer som RNA terapeutikske midler
CO2017001493A2 (es) Kits que comprenden inhibidores tigit y agentes anticáncer
IL285553A (en) Use of prg4 as an anti-inflammatory agent
CY1123354T1 (el) Συνθεσεις τοπικης εφαρμογης που περιλαμβανουν ενα κορτικοστεροειδες και ενα ρετινοειδες για τη θεραπεια της ψωριασης
CL2016002027A1 (es) Ciclopropilamina como inhibidor de la lsd1
NI201600051A (es) Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores
CL2015002658A1 (es) Derivados de 2, 3 - disustituto 1- acil -4 amino - 1,2,3,4 tetrahidroquinilina y su uso como inhibidores de bromodominio
BR112015022625A2 (pt) micromatrizes para entrega de agente terapêutico e métodos de uso
AR102553A1 (es) Terapia de combinación con agonistas de unión ox40 e inhibidores de tigit
DK3641819T3 (da) Anvendelse af cannabidiol i behandling af tuberøst sklerosekompleks
CR20160485A (es) Compuesto de ciclopropanamina y sus usos
BR112016022667A2 (pt) Uso de álcool d-pantotenílico para a fabricação de inibidor de melanogênese e método de branquear a pele
EA201691808A8 (ru) Кортикостероидные композиции для местного применения
BR112016023815A2 (pt) composições tópicas para o alívio da dor, produção e uso
BR112018006103A2 (pt) aplicador de precisão
CO2019006113A2 (es) Pulverizador
CO2017001626A2 (es) Anticuerpo anti-orai1
BR112018006870A2 (pt) nanopartículas terapêuticas que compreendem um agente terapêutico e métodos para a produção e o uso das mesmas
DK3727414T3 (da) Salvia haenkei-ekstrakt som aktivt middel i vævsreepiteliserings- og ardannelsesprocesser
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
IT201700085412A1 (it) Composizione per uso nella prevenzione e nel trattamento di patologie dell&#39;apparato cardiovascolare
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
IT201700111939A1 (it) Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
EA201891351A1 (ru) Вспениваемая композиция галобетазола и способ её применения
IT201700111261A1 (it) Composizione per il trattamento delle neuropatie metaboliche e meccaniche